Public Comments to FDA Help Define ‘Black Market’

From: CSP

By Angel Abcede, Senior Editor/Tobacco, CSP

WASHINGTON – One of the byproducts of the U.S. Food and Drug Administration’s (FDA’s) round of public discussion around nicotine levels in cigarettes is a rush of reports surrounding one of the tobacco category’s biggest challenges: the black market.

Illicit trade is a big argument that major tobacco makers put up against any potential standard for lowering nicotine levels in cigarettes sold in the United States.

Read Complete Article

Permalink

Leave a Reply

Your email address will not be published.

Please Answer: *